Home » Archive

NYSE:PFE

NYSE:PFE »

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

Posted by Mary Canady October 5th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur…

More...